SEC Company Response from Cardiff Oncology, Inc. (CRDF) (CIK 0001213037) (CRDF) — Nov 12, 2019
Cardiff Oncology, Inc. (CRDF) (CIK 0001213037)
Date: Nov. 12, 2019 · CIK: 0001213037 · Accession: 0001104659-19-062115
AI Filing Summary & Sentiment
File numbers found in text: 333-234442
Letter
Trovagene, Inc.
11055 Flintkote Avenue
San Diego, CA 92921
November 12, 2019
VIA EDGAR
United States Securities
and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention: Greg Dundas
Re: Trovagene Inc.
Registration Statement on Form S-1, as amended
File No. 333-234442
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), Trovagene, Inc. (the “Company”) respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 5:00 p.m., Eastern Standard Time, on Wednesday, November 13, 2019, or as soon thereafter as possible.
Please notify Jeffrey Fessler of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (212) 634-3067 as soon as possible as to the time the Registration Statement has been declared effective pursuant to this acceleration request.
Thank you,
TROVAGENE, INC.
By:
/s/ Thomas H. Adams
Name:
Thomas H. Adams
Title:
Chief Executive Officer
Show Raw Text
CORRESP 1 filename1.htm Trovagene, Inc. 11055 Flintkote Avenue San Diego, CA 92921 November 12, 2019 VIA EDGAR United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attention: Greg Dundas Re: Trovagene Inc. Registration Statement on Form S-1, as amended File No. 333-234442 Ladies and Gentlemen: Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), Trovagene, Inc. (the “Company”) respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 5:00 p.m., Eastern Standard Time, on Wednesday, November 13, 2019, or as soon thereafter as possible. Please notify Jeffrey Fessler of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (212) 634-3067 as soon as possible as to the time the Registration Statement has been declared effective pursuant to this acceleration request. Thank you, TROVAGENE, INC. By: /s/ Thomas H. Adams Name: Thomas H. Adams Title: Chief Executive Officer